LEXX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lexaria Bioscience Corp

Watchlist Manager

Watchlist

Price: 0.5402 USD -11.52% Market Closed

Market Cap: $13.4m

	Lexaria Bioscience Corp NASDAQ:LEXX	CA
C	Ctac NV XBER:TAC	NL
C	Ctac NV F:TAC	NL

Profitability Summary

Lexaria Bioscience Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

79% > 100%

Negative Operating Margin

-2 572%

Negative 3Y Average Operating Margin

-1 865%

Declining Operating Margin

-2 050% > -2 572%

Negative Net Margin

-2 590%

Negative 3Y Average Net Margin

-1 872%

Declining Net Margin

-2 029% > -2 590%

Negative Free Cash Flow Margin

-2 612%

Negative 3Y Average Free Cash Flow Margin

-1 702%

Declining Free Cash Flow Margin

-1 644% > -2 612%

Negative ROE

-139%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-659%

Declining ROIC

-553% > -929%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.